Please assess the completion status of the following clinical trial:

Trial Title: A Multiple Dose Safety And Pharmacokinetic (PK) Study Of PF-06427878 In Overweight-Obese, Otherwise Healthy Subjects

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy male and/or female subjects of non childbearing potential.~* Body Mass Index (BMI) of \>=25 kg/m2; and a total body weight \>50 kg~* Subjects with liver fat \>=6% and \<=20%~Exclusion Criteria:~* Evidence or history of clinically significant hematological, renal, endocrine, pulmonary,gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic, or allergic disease (including drug allergies, but excluding untreated, asymptomatic, seasonal allergies at time of dosing).

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: t

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): Placebo will be administered as an extemporaneously prepared suspension every 8 hours for 14 days
- PF-06427878 (Type: EXPERIMENTAL): PF-06427878 will be administered as an extemporaneously prepared suspension every 8 hours for 14 days

Based on this trial design, predict the completion outcome and termination type (if applicable).